BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18604515)

  • 1. ADAM12: a potential target for the treatment of chronic wounds.
    Harsha A; Stojadinovic O; Brem H; Sehara-Fujisawa A; Wewer U; Loomis CA; Blobel CP; Tomic-Canic M
    J Mol Med (Berl); 2008 Aug; 86(8):961-9. PubMed ID: 18604515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
    Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
    Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation.
    Yahata Y; Shirakata Y; Tokumaru S; Yang L; Dai X; Tohyama M; Tsuda T; Sayama K; Iwai M; Horiuchi M; Hashimoto K
    J Biol Chem; 2006 May; 281(19):13209-13216. PubMed ID: 16543233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated wound repair in ADAM-9 knockout animals.
    Mauch C; Zamek J; Abety AN; Grimberg G; Fox JW; Zigrino P
    J Invest Dermatol; 2010 Aug; 130(8):2120-30. PubMed ID: 20376065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
    Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
    Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein signaling suppresses wound-induced skin repair by inhibiting keratinocyte proliferation and migration.
    Lewis CJ; Mardaryev AN; Poterlowicz K; Sharova TY; Aziz A; Sharpe DT; Botchkareva NV; Sharov AA
    J Invest Dermatol; 2014 Mar; 134(3):827-837. PubMed ID: 24126843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
    Stautz D; Wewer UM; Kveiborg M
    PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular roles of ADAM12 in health and disease.
    Kveiborg M; Albrechtsen R; Couchman JR; Wewer UM
    Int J Biochem Cell Biol; 2008; 40(9):1685-702. PubMed ID: 18342566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
    Aghababaei M; Perdu S; Irvine K; Beristain AG
    Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing.
    Stojadinovic O; Brem H; Vouthounis C; Lee B; Fallon J; Stallcup M; Merchant A; Galiano RD; Tomic-Canic M
    Am J Pathol; 2005 Jul; 167(1):59-69. PubMed ID: 15972952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation.
    Kveiborg M; Albrechtsen R; Rudkjaer L; Wen G; Damgaard-Pedersen K; Wewer UM
    J Bone Miner Res; 2006 Aug; 21(8):1288-96. PubMed ID: 16869727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
    Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
    Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing.
    Holt JR; Zeng WZ; Evans EL; Woo SH; Ma S; Abuwarda H; Loud M; Patapoutian A; Pathak MM
    Elife; 2021 Sep; 10():. PubMed ID: 34569935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.
    Shirakata Y; Kimura R; Nanba D; Iwamoto R; Tokumaru S; Morimoto C; Yokota K; Nakamura M; Sayama K; Mekada E; Higashiyama S; Hashimoto K
    J Cell Sci; 2005 Jun; 118(Pt 11):2363-70. PubMed ID: 15923649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
    Dyczynska E; Syta E; Sun D; Zolkiewska A
    Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice.
    Oshio T; Komine M; Tsuda H; Tominaga SI; Saito H; Nakae S; Ohtsuki M
    J Dermatol Sci; 2017 Feb; 85(2):106-114. PubMed ID: 27839630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
    J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.